Literature DB >> 313841

The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.

K Sugimura, M Uemiya, I Saiki, I Azuma, Y Yamamura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313841     DOI: 10.1016/0008-8749(79)90157-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  12 in total

Review 1.  A systemic study of enhancement of host defense processes against bacterial infection.

Authors:  H C Polk
Journal:  Jpn J Surg       Date:  1988-11

2.  Enhancement of antigen-specific suppression by muramyl dipeptide.

Authors:  T A Ferguson; N J Krieger; A Pesce; J G Michael
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

3.  Adjuvant activity of purified peptidoglycan of Listeria monocytogenes in mice and guinea pigs.

Authors:  I Saiki; K Kamisango; Y Tanio; H Okumura; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

Review 4.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

5.  Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).

Authors:  M Akasaki; T Takashi; Y Kita; W Tsukada
Journal:  Agents Actions       Date:  1987-10

6.  Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.

Authors:  T Furuya; Y Kumazawa; H Takimoto; T Nagumo; M Watanabe; C Aizawa; M Kiso; A Hasegawa; K Nomoto
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

7.  Stimulatory effect of N-acetyl Muramyl dipeptide in vivo: proliferation of bone marrow progenitor cells in mice.

Authors:  B Wuest; E D Wachsmuth
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

8.  Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.

Authors:  L E Adinolfi; P F Bonventre; M Vander Pas; D A Eppstein
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

9.  Stimulation of chemiluminescence by synthetic muramyl dipeptide and analogs.

Authors:  K N Masihi; I Azuma; W Brehmer; W Lange
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Chronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP).

Authors:  H B Richerson; M T Suelzer; P A Swanson; J E Butler; W C Kopp; E F Rose
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.